Heidelberg, Germany

Stefan Heinz

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Curevac Manufacturing Gmbh. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefan Heinz. Retrieved from https://idiyas.com/inventor/stefan-heinz-9ic3d6g7

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stefan Heinz

Introduction

Stefan Heinz is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of RNA quality control analysis. His work is particularly relevant in the pharmaceutical industry, where the quality of RNA samples is crucial for various applications.

Latest Patents

Stefan Heinz holds a patent for a method that determines at least one quality parameter of an RNA sample. This invention involves a quality control analysis of RNA samples comprising different RNA molecule species using reverse transcription and a polymerase chain reaction (PCR) based assay, specifically digital PCR (dPCR), preferably droplet digital PCR (ddPCR). The method is designed to assess the quality of RNA molecules, which may be in complexed form, making it suitable for quality control during or after the production of RNA samples for pharmaceutical use.

Career Highlights

Stefan Heinz is currently employed at Curevac Manufacturing GmbH, where he applies his expertise in RNA technology. His innovative approach to RNA quality control has positioned him as a valuable asset in the field. His work not only enhances the understanding of RNA quality parameters but also contributes to the advancement of pharmaceutical applications.

Collaborations

Stefan collaborates with Tilmann Roos, leveraging their combined expertise to further enhance the quality control processes in RNA sample production.

Conclusion

Stefan Heinz's contributions to RNA quality control through his innovative patent demonstrate his commitment to advancing pharmaceutical technologies. His work is essential for ensuring the reliability and effectiveness of RNA samples in various applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…